Biopharma valuations—onward and upward?
Companies focused on biopharma have done well in capital markets. A closer look at performance helps explain why.
Companies focused on biopharma have done well in capital markets. A closer look at performance helps explain why.
Source: McKinsey

Biopharma valuations—onward and upward?